# Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

> **NCT05223218** · — · UNKNOWN · sponsor: **Namida Lab** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Melanoma

## Interventions

- **OTHER:** Schirmer strip, a Class I Medical Device typically used to test for dry eye.

## Key facts

- **NCT ID:** NCT05223218
- **Lead sponsor:** Namida Lab
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-25
- **Primary completion:** 2023-11
- **Final completion:** 2023-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-07-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05223218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05223218, "Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05223218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*